These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26028646)

  • 1. Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments.
    Lai R; Afkhami S; Haddadi S; Jeyanathan M; Xing Z
    Eur Respir Rev; 2015 Jun; 24(136):356-60. PubMed ID: 26028646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
    PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model.
    Damjanovic D; Khera A; Afkhami S; Lai R; Zganiacz A; Jeyanathan M; Xing Z
    PLoS One; 2015; 10(6):e0131175. PubMed ID: 26098423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.
    Wang J; Thorson L; Stokes RW; Santosuosso M; Huygen K; Zganiacz A; Hitt M; Xing Z
    J Immunol; 2004 Nov; 173(10):6357-65. PubMed ID: 15528375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection.
    Dijkman K; Aguilo N; Boot C; Hofman SO; Sombroek CC; Vervenne RAW; Kocken CHM; Marinova D; Thole J; Rodríguez E; Vierboom MPM; Haanstra KG; Puentes E; Martin C; Verreck FAW
    Cell Rep Med; 2021 Jan; 2(1):100187. PubMed ID: 33521701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway delivery of soluble mycobacterial antigens restores protective mucosal immunity by single intramuscular plasmid DNA tuberculosis vaccination: role of proinflammatory signals in the lung.
    Jeyanathan M; Mu J; Kugathasan K; Zhang X; Damjanovic D; Small C; Divangahi M; Petrof BJ; Hogaboam CM; Xing Z
    J Immunol; 2008 Oct; 181(8):5618-26. PubMed ID: 18832720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a prime and pull approach, lentivector vaccines expressing Ag85A induce immunogenicity but fail to induce protection against Mycobacterium bovis bacillus Calmette-Guérin challenge in mice.
    Britton G; MacDonald DC; Brown JS; Collins MK; Goodman AL
    Immunology; 2015 Oct; 146(2):264-70. PubMed ID: 26095282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine-Induced T Cells to Both the Lung Parenchyma and Airway.
    Jeyanathan M; Afkhami S; Khera A; Mandur T; Damjanovic D; Yao Y; Lai R; Haddadi S; Dvorkin-Gheva A; Jordana M; Kunkel SL; Xing Z
    J Immunol; 2017 Oct; 199(7):2555-2569. PubMed ID: 28827285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal luminal manipulation of T cell geography switches on protective efficacy by otherwise ineffective parenteral genetic immunization.
    Santosuosso M; McCormick S; Roediger E; Zhang X; Zganiacz A; Lichty BD; Xing Z
    J Immunol; 2007 Feb; 178(4):2387-95. PubMed ID: 17277145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.
    Jeyanathan M; Heriazon A; Xing Z
    Trends Immunol; 2010 Jul; 31(7):247-52. PubMed ID: 20542470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral Vaccination With a Tuberculosis Subunit Vaccine in Presence of Retinoic Acid Provides Early but Transient Protection to
    Riccomi A; Piccaro G; Christensen D; Palma C; Andersen P; Vendetti S
    Front Immunol; 2019; 10():934. PubMed ID: 31130946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.
    Gupta T; LaGatta M; Helms S; Pavlicek RL; Owino SO; Sakamoto K; Nagy T; Harvey SB; Papania M; Ledden S; Schultz KT; McCombs C; Quinn FD; Karls RK
    Tuberculosis (Edinb); 2018 Dec; 113():179-188. PubMed ID: 30514501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of B Cells in Mucosal Vaccine-Induced Protective CD8+ T Cell Immunity against Pulmonary Tuberculosis.
    Khera AK; Afkhami S; Lai R; Jeyanathan M; Zganiacz A; Mandur T; Hammill J; Damjanovic D; Xing Z
    J Immunol; 2015 Sep; 195(6):2900-7. PubMed ID: 26268652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary (i.pulmon.) Pull Immunization With the Tuberculosis Subunit Vaccine Candidate H56/CAF01 After Intramuscular (i.m.) Priming Elicits a Distinct Innate Myeloid Response and Activation of Antigen-Presenting Cells Than i.m. or i.pulmon. Prime Immunization Alone.
    Thakur A; Pinto FE; Hansen HS; Andersen P; Christensen D; Janfelt C; Foged C
    Front Immunol; 2020; 11():803. PubMed ID: 32457748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.
    Hu Z; Wong KW; Zhao HM; Wen HL; Ji P; Ma H; Wu K; Lu SH; Li F; Li ZM; Shu T; Xu JQ; Lowrie DB; Fan XY
    Mol Ther; 2017 May; 25(5):1222-1233. PubMed ID: 28342639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
    Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
    Front Immunol; 2018; 9():2825. PubMed ID: 30555488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.
    Urdahl KB
    Semin Immunol; 2014 Dec; 26(6):578-87. PubMed ID: 25453230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal bovine β-defensin-5 enhances antituberculosis immunity in a mouse model by a novel protein-based respiratory mucosal vaccine.
    Liang Z; Li H; Qu M; Liu Y; Wang Y; Wang H; Dong Y; Chen Y; Ge X; Zhou X
    Virulence; 2022 Dec; 13(1):949-962. PubMed ID: 35603910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity.
    Dietrich J; Andersen C; Rappuoli R; Doherty TM; Jensen CG; Andersen P
    J Immunol; 2006 Nov; 177(9):6353-60. PubMed ID: 17056566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.